Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer progression. The pipeline includes cirmtuzumab, a monoclonal antibody in Phase 1/2 development that inhibits the ROR1 receptor in various hematologic cancers; TK-216, a small-molecule in Phase 1 development that inhibits ETS-family oncoproteins, as a treatment for Ewing sarcoma, a rare pediatric cancer; and a CAR-T therapy that targets ROR1 currently in preclinical development as a potential treatment for solid tumors and hematologic cancers. Based in San Diego, Oncternal is committed to advancing its pipeline rapidly and efficiently to bring patients a new wave of first-in-class cancer treatments.
View Top Employees from Oncternal TherapeuticsWebsite | http://www.oncternal.com |
Ticker | ONCT |
Revenue | $16 million |
Employees | 37 (33 on RocketReach) |
Founded | 2013 |
Address | 12230 El Camino Real Suite 300, San Diego, California 92130, US |
Phone | (858) 434-1113 |
Fax | (858) 408-3010 |
Technologies |
JavaScript,
HTML,
Twitter
+25 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering, Health Care, Health Diagnostics, Therapeutics |
Competitors | Applied Therapeutics Inc, GlycoMimetics, Neurodyn Inc., Receptos, a wholly-owned subsidiary of Celgene, Soligenix, Inc. |
SIC | SIC Code 283 Companies, SIC Code 873 Companies, SIC Code 28 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 325 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 32 Companies, NAICS Code 5417 Companies |
Looking for a particular Oncternal Therapeutics employee's phone or email?
The Oncternal Therapeutics annual revenue was $16 million in 2024.
Rajesh Krishnan is the Chief Technical Officer of Oncternal Therapeutics.
33 people are employed at Oncternal Therapeutics.
Oncternal Therapeutics is based in San Diego, California.
The NAICS codes for Oncternal Therapeutics are [541, 54, 325, 54171, 541714, 32, 5417].
The SIC codes for Oncternal Therapeutics are [283, 873, 28, 87].